๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Lymphocytes

A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs) NCT07743190Phase 22 sites๐Ÿ“ Syracuse๐Ÿ“ Charleston Medical University of South Carolina ยท Tests: Carboplatin, Paclitaxcel, Pembrolizumab Combined Predictive Value of RSBI and CALLY Index in Predicting Weaning Success in ICU Patients NCT07571317n/a1 site๐Ÿ“ Istanbul Istanbul University - Cerrahpasa Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) NCT03266640Phase 29 sites๐Ÿ“ Los Angeles๐Ÿ“ San Francisco๐Ÿ“ Indianapolis New York Medical College ยท Tests: viral specific cytotoxic t-lymphocytes Advanced Therapies for Liver Metastases NCT04622423n/a1 site๐Ÿ“ Milan IRCCS San Raffaele T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer NCT02133196Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Aldesleukin, Fludarabine, Cyclophosphamide, Young TIL TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT. NCT04013802Phase 12 sites๐Ÿ“ Houston๐Ÿ“ Houston Baylor College of Medicine ยท Tests: HLA-matched VSTs EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection NCT03266653Phase 28 sites๐Ÿ“ Los Angeles๐Ÿ“ San Francisco๐Ÿ“ Baltimore New York Medical College ยท Tests: cytotoxic t-lymphocytes A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab NCT02621021Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: young TIL, Pembrolizumab, Aldesleukin, Fludarabine, Cyclophosphamide Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy NCT06895538Phase 2, Phase 31 site๐Ÿ“ Beijing Peking University First Hospital ยท Tests: Rabbit Anti-Human T-Lymphocyte Immunoglobulin (ATLG) A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. NCT06481592Phase 212 sites๐Ÿ“ Phoenix๐Ÿ“ Los Angeles๐Ÿ“ Orlando Iovance Biotherapeutics, Inc. ยท Tests: Lifileucel Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis NCT06569472Phase 11 site๐Ÿ“ Hangzhou Chongqing Precision Biotech Co., Ltd ยท Tests: CD19-targetd CAR-T Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer NCT06865339Phase 21 site๐Ÿ“ The Bronx Montefiore Medical Center ยท Tests: Cemiplimab, Fianlimab, Radiotherapy, Platinum Doublet Chemotherapy (PDC) TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients NCT06455917Phase 21 site๐Ÿ“ Basel University Hospital, Basel, Switzerland ยท Tests: TILs๏ผˆTumor Infiltrating Lymphocytes๏ผ‰ Trial to Assess the Safety and Feasibility of Adoptive Cell Therapy with Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients with a First Clinical Episode Highly Suggestive of Multiple Sclerosis NCT02912897Phase 11 site๐Ÿ“ Nantes Nantes University Hospital ยท Tests: Cellular therapy with EBV specific autologous CTL infusion Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC) NCT06564623Phase 11 site๐Ÿ“ Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: mBTC vax [0.3 - 2.4 mg peptide + 0.5 mg Poly-ICLC (Hiltonol)], Durvalumab, Tremelimumab Maltodextrin Versus Sugar Water Carbohydrate Loading and Gastric Volume in Geriatric Lower Limb Orthopedic Surgery NCT07872683NA1 site๐Ÿ“ Denpasar Udayana University ยท Tests: Maltodextrin carbohydrate drink, Sugar water Immunological Aspect of Thrombotic Thrombocytopenic Purpura (TTP) NCT06945861n/a1 site๐Ÿ“ Rouen University Hospital, Rouen Effects of Eccentric Exercise Training in Patients With COPD NCT06168266NA1 site๐Ÿ“ New Taipei City Fu Jen Catholic University ยท Tests: Eccentric bike, conventional group Randomised Controlled Trial Comparing CD62L and CD45RA Depleted Donor Lymphocyte Infusion With T-cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation NCT07867769Phase 21 site๐Ÿ“ Hong Kong Hong Kong Children's Hospital ยท Tests: CD62L depleted DLI, CD45RA depleted DLI, Haploidentical HSCT SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease NCT04896606Phase 1, Phase 24 sites๐Ÿ“ Valhalla๐Ÿ“ Columbus๐Ÿ“ Philadelphia New York Medical College ยท Tests: Standard of Care, SARS-CoV2-CTLS Long-term Follow up Local Registry Study of Kymriah in South Korea NCT06785818n/a18 sites๐Ÿ“ Bundang Gu๐Ÿ“ Seongnam-si๐Ÿ“ Gyeonggi-do Novartis Pharmaceuticals ยท Tests: Tisagenlecleucel A Study of TIL in Advanced Solid Tumors (DFGD) NCT06488950EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Juncell Therapeutics ยท Tests: GC203 TIL(gene-edited TIL) or autologous TILs Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: biologic sample preservation procedure, cytology specimen collection procedure Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT NCT01962415Phase 21 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: Hydroxyurea, Alemtuzumab, Fludarabine, Melphalan, Thiotepa CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT NCT07441291Phase 31 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: CAR-T, DLI A Comparative Study Between Neutrophil/Lymphocyte Ratio and Lactate/Albumin Ratio as Predictive Inflammatory Markers for Sepsis NCT07089524n/a1 site๐Ÿ“ Cairo Ain Shams University To Evaluate the Safety of Autologous Tumor-infiltrating Lymphocytes(TILs) for the Treatment of Recurrent Ovarian Cancer NCT07651124NA1 site๐Ÿ“ Gyeonggi-do Yong Wha Moon ยท Tests: autologous tumor-infiltrating lymphocytes Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies NCT05327023Phase 1, Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: donor lymphocyte infusion, Cyclophosphamide, Busulfan, Mycophenolate mofetil, Fludarabine Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivoยฎ as Adjuvant Monotherapy in Participants With Melanoma NCT07476326Phase 146 sites๐Ÿ“ Bento Gonรงalves๐Ÿ“ Ijuรญ๐Ÿ“ Parรก Biocon Biologics UK PLC ยท Tests: Bmab1700, Opdivo Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases NCT05383339n/a1 site๐Ÿ“ Paris Assistance Publique - Hรดpitaux de Paris ยท Tests: Blood collection
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy